SCREENERS
Caregiver Strain Index & PHQ-2

Caregiver Stress and Mood Screening Tool

Caregiver Stress and Mood Screening Tool

The Caregiver Strain Index & PHQ-2 is a combined screening tool that pairs two validated instruments to support a comprehensive picture of caregiver well-being. The Caregiver Strain Index is a standardized tool used to assess caregiver stress and perceived burden, while the PHQ-2 is a brief, two-item questionnaire used to screen for mood-related symptoms, including depressed mood and loss of interest. Together, they provide structured, efficient documentation of caregiver mental and emotional health in clinical settings.

Delivered digitally through the BrainCheck platform, this combined screener can be completed in approximately 1–3 minutes by a caregiver, either in-clinic or remotely, and supports identification of caregivers who may benefit from additional support or resources.

Benefits include:

  • Combines two validated instruments into a single, efficient caregiver screening workflow.
  • Identifies caregiver strain and mood concerns that may require additional support or intervention.
  • Completed in 1–3 minutes by caregivers in-clinic or remotely, with minimal burden.
  • Structured scoring supports documentation and care planning for both patient and caregiver.

What the Caregiver Strain Index & PHQ-2 Measures 


Caregiver stress levels and perceived burden associated with caregiving responsibilities.


Areas of strain such as time demands, physical effort, financial impact, and social limitations.


Mood-related symptoms in the caregiver, including depressed mood and loss of interest over the prior two weeks.

Common Clinical Use Cases

  • Caregiver well-being screening in dementia care, geriatrics, and chronic illness management.
  • Identifying caregivers at risk for strain or mood-related concerns to support proactive intervention.
  • Care planning workflows that incorporate caregiver health alongside patient assessments.
  • Supporting referrals to caregiver support services, counseling, or community resources.

On the BrainCheck Platform

  • Fully digital, caregiver self-administered on tablets or computers, or completed remotely.
  • Scored instrument with structured results supporting clinical documentation.
  • Integrates caregiver well-being data alongside patient cognitive and functional assessments within BrainCheck.
  • Supports caregiver-inclusive care models within comprehensive dementia and chronic care workflows.

Frequently Asked Questions

Key things to know about the Caregiver Strain Index & PHQ-2

What is the Caregiver Strain Index & PHQ-2?

The Caregiver Strain Index & PHQ-2 is a combined screening tool that assesses caregiver stress and perceived burden alongside brief mood symptom screening. Together, they support documentation of caregiver well-being and help identify caregivers who may benefit from additional support.

Who completes this screening tool?

This tool is completed by the caregiver — the person providing care to the patient. It is not completed by the patient themselves.

Is the Caregiver Strain Index & PHQ-2 a diagnostic tool?

No. This is a screening tool, not a diagnostic instrument. Results are intended to support clinical judgment and guide follow-up evaluation, care planning, or referral to supportive resources.

How long does it take to complete?

The combined screener typically takes 1–3 minutes to complete, making it practical for routine integration into clinical visits or remote pre-visit workflows.

How does delivering this tool through BrainCheck support caregiver care?

On BrainCheck, the Caregiver Strain Index & PHQ-2 is digitally self-administered by the caregiver, automatically scored, and integrated into care planning workflows, allowing caregiver well-being data to inform clinical decisions alongside patient assessments.

More Clinical Evaluation Tools

BrainCheck offers a broad library of clinical evaluation tools designed to support early identification, risk stratification, and longitudinal monitoring of cognitive health across clinical and research settings.